Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)

Yang Zhang; Xiaoyi Chen; Huamin Wang; Shanisha Gordon-Mitchell; Srabani Sahu; Tushar D. Bhagat; Gaurav Choudhary; Srinivas Aluri; Kith Pradhan; Plabani Sahu; Milagros Carbajal; Hui Zhang; Beamon Agarwal; Aditi Shastri; Robert Martell; Daniel Starczynowski; Ulrich Steidl; Anirban Maitra; Amit Verma

doi:10.1186/s13045-022-01321-4

Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)

Yang Zhang
, Xiaoyi Chen
, Huamin Wang
, Shanisha Gordon-Mitchell
, Srabani Sahu
, Tushar D. Bhagat
, Gaurav Choudhary
, Srinivas Aluri
, Kith Pradhan
, Plabani Sahu
, Milagros Carbajal
, Hui Zhang
, Beamon Agarwal
, Aditi Shastri
, Robert Martell
, Daniel Starczynowski
, Ulrich Steidl
, Anirban Maitra
, Amit Verma

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original article erroneously omitted the following Conflict of Interest statement: Dr. Maitra receives royalties from Cosmos Wisdom Biotech for a license related to a pancreatic cancer early detection test. He is also listed as an inventor on a patent licensed to Thrive Earlier Detection Ltd (an Exact Sciences Company) and serves as a consultant for Freenome and Tezcat Biotechnology.

Original language	English (US)
Article number	100
Journal	Journal of Hematology and Oncology
Volume	15
Issue number	1
DOIs	https://doi.org/10.1186/s13045-022-01321-4
State	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Molecular Biology
Oncology
Cancer Research

Access to Document

10.1186/s13045-022-01321-4

Fingerprint

Dive into the research topics of 'Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)'. Together they form a unique fingerprint.

Cite this

Zhang, Y., Chen, X., Wang, H., Gordon-Mitchell, S., Sahu, S., Bhagat, T. D., Choudhary, G., Aluri, S., Pradhan, K., Sahu, P., Carbajal, M., Zhang, H., Agarwal, B., Shastri, A., Martell, R., Starczynowski, D., Steidl, U., Maitra, A., & Verma, A. (2022). Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4). Journal of Hematology and Oncology, 15(1), Article 100. https://doi.org/10.1186/s13045-022-01321-4

Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4). / Zhang, Yang; Chen, Xiaoyi; Wang, Huamin et al.
In: Journal of Hematology and Oncology, Vol. 15, No. 1, 100, 12.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Zhang, Y, Chen, X, Wang, H, Gordon-Mitchell, S, Sahu, S, Bhagat, TD, Choudhary, G, Aluri, S, Pradhan, K, Sahu, P, Carbajal, M, Zhang, H, Agarwal, B, Shastri, A, Martell, R, Starczynowski, D, Steidl, U, Maitra, A & Verma, A 2022, 'Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)', Journal of Hematology and Oncology, vol. 15, no. 1, 100. https://doi.org/10.1186/s13045-022-01321-4

Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD et al. Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4). Journal of Hematology and Oncology. 2022 Dec;15(1):100. doi: 10.1186/s13045-022-01321-4

@article{dd516920dd5342a3bd0f4d9c6f1e9ce4,

title = "Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology \& Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)",

abstract = "The original article erroneously omitted the following Conflict of Interest statement: Dr. Maitra receives royalties from Cosmos Wisdom Biotech for a license related to a pancreatic cancer early detection test. He is also listed as an inventor on a patent licensed to Thrive Earlier Detection Ltd (an Exact Sciences Company) and serves as a consultant for Freenome and Tezcat Biotechnology.",

author = "Yang Zhang and Xiaoyi Chen and Huamin Wang and Shanisha Gordon-Mitchell and Srabani Sahu and Bhagat, \{Tushar D.\} and Gaurav Choudhary and Srinivas Aluri and Kith Pradhan and Plabani Sahu and Milagros Carbajal and Hui Zhang and Beamon Agarwal and Aditi Shastri and Robert Martell and Daniel Starczynowski and Ulrich Steidl and Anirban Maitra and Amit Verma",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1186/s13045-022-01321-4",

language = "English (US)",

volume = "15",

journal = "Journal of Hematology and Oncology",

issn = "1756-8722",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)

AU - Zhang, Yang

AU - Chen, Xiaoyi

AU - Wang, Huamin

AU - Gordon-Mitchell, Shanisha

AU - Sahu, Srabani

AU - Bhagat, Tushar D.

AU - Choudhary, Gaurav

AU - Aluri, Srinivas

AU - Pradhan, Kith

AU - Sahu, Plabani

AU - Carbajal, Milagros

AU - Zhang, Hui

AU - Agarwal, Beamon

AU - Shastri, Aditi

AU - Martell, Robert

AU - Starczynowski, Daniel

AU - Steidl, Ulrich

AU - Maitra, Anirban

AU - Verma, Amit

PY - 2022/12

Y1 - 2022/12

N2 - The original article erroneously omitted the following Conflict of Interest statement: Dr. Maitra receives royalties from Cosmos Wisdom Biotech for a license related to a pancreatic cancer early detection test. He is also listed as an inventor on a patent licensed to Thrive Earlier Detection Ltd (an Exact Sciences Company) and serves as a consultant for Freenome and Tezcat Biotechnology.

AB - The original article erroneously omitted the following Conflict of Interest statement: Dr. Maitra receives royalties from Cosmos Wisdom Biotech for a license related to a pancreatic cancer early detection test. He is also listed as an inventor on a patent licensed to Thrive Earlier Detection Ltd (an Exact Sciences Company) and serves as a consultant for Freenome and Tezcat Biotechnology.

UR - https://www.scopus.com/pages/publications/85134759463

UR - https://www.scopus.com/pages/publications/85134759463#tab=citedBy

U2 - 10.1186/s13045-022-01321-4

DO - 10.1186/s13045-022-01321-4

M3 - Comment/debate

C2 - 35883108

AN - SCOPUS:85134759463

SN - 1756-8722

VL - 15

JO - Journal of Hematology and Oncology

JF - Journal of Hematology and Oncology

IS - 1

M1 - 100

ER -

Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (Journal of Hematology & Oncology, (2022), 15, 1, (70), 10.1186/s13045-022-01286-4)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this